Clinical Study Backs Claims Made by Skincare Brand SkinAx²

636087525874528747femme_dans_bulle.jpg

06 Sep 2016 --- SkinAx², a new anti-aging formula from the French Group Activ’Inside, has been backed by a published clinical study on its capacity to improve skin radiance by oral route.

The oral supplement provides both primary and secondary antioxidants for an optimal and synergistic protection against skin oxidation, combining french grape and melon extracts rich in polyphenols, as well as superOxide Dismutase (SOD), zinc and vitamin C.

The makers claim the antioxidant capacity of SkinAx² protects skin fibers from degradation, improves skin microcirculation and allows regulating melanin synthesis. This multifactorial way of action contributes to the complete effect of SkinAx² on the three main components of skin radiance: color, contract and imperfection.

It's these claims have now been backed by a clinical study conducted under dermatological control on 35 women. Using both subjective and objective methods, SkinAx² was found to improve skin radiance, including color, contrast and imperfection after 2 months of oral supplementation. 82 per cent of women enrolled on the study reported an even complexion and brighter skin.

Marion Dumoulin, co-author of the clinical study explained, “Contrary to most of skin anti-aging solutions, SkinAx² not only acts on a single parameter but has a full and complementary action on all factors involved in skin radiance."

Dumoulin added, “Consumer’s skin is more luminous, smoother and firmer, with less imperfections. Overall, more than 20 clinical results detailing the SkinAx² efficacy have been obtained, each representing one validated differentiating message for the final consumers.”

The innovation provided by SkinAx² on the nutricosmetic market has already been rewarded twice and has been selected as a finalist of CPG Editor’s Choice Award, whose winner will be selected at the upcoming Supply Side West event. This recognition of the product highlights the innovation conveyed by SkinAx² on the growing nutricosmetic market.

When asked how he thinks the nutricosmetic sector will move forward, Benoit Lemaire, Business & Marketing Director of Activ’Inside, told NutritionInsight: "In our opinion, the nutricosmetic industry will move to the development of ready to use formulations based on the combination of synergistic ingredients. Customers have growing interest in having a full formula backed by clinical studies and claims in order to accelerate their market access and to boost their communication"

Available both as an ingredient or a ready-to-use formulation for private labeling, Lemaire added that SkinAx² can be used adapted to the customer needs, explaining, "We propose turnkey concepts formulated with SkinAx² allowing our customers to access to the market with an innovative product backed by one clinical study, a patented formula, and proprietary claims.”

by Hannah Gardiner

Related Articles

Nutrition & Health News

Yogurt may reduce cardiovascular disease risk

19 Feb 2018 --- A higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women, a study in the American Journal of Hypertension suggests. High blood pressure is a major cardiovascular disease risk factor. Clinical trials have previously demonstrated beneficial effects of dairy consumption on cardiovascular health, and yogurt may independently be related to cardiovascular disease risk.

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

A gold medal for recovery? FrieslandCampina DMV develops innovative casein isolate 

14 Feb 2018 --- FrieslandCampina DMV has introduced their latest innovation in dairy protein ingredients. Micelate Prestige has been launched this week in Europe and is a key addition to the company’s growing portfolio of Performance Nutrition solutions. 

Nutrition & Health News

Clear definition and regulations needed to tap into nutraceuticals’ potential: review

13 Feb 2018 --- Nutraceuticals with health benefits substantiated by clinical data can be powerful tools to prevent and treat medical conditions, especially in individuals who may not yet be eligible for conventional pharmaceutical drugs. However, there is a clear need for clear regulations to ensure their safety. This is according to a review published in the British Journal of Clinical Pharmacology, which further proposes a clear definition for this type of product. 

More Articles
URL : http://www.nutritioninsight.com:80/news/clinical-study-backs-claims-made-by-skincare-brand-skinax.html